Target intelligence / Profile preview

Ribosomal protein L7 pseudogene 5 (RPL7P5)

Target
RPL7P5
Molecular classification
Other (Processed pseudogene)
01

Overview

RPL7P5 is one of multiple processed pseudogenes for the ribosomal protein L7 (RPL7) gene, found dispersed throughout the human genome. Unlike the functional RPL7 gene, which codes for a constituent protein of the 60S ribosomal subunit, processed pseudogenes such as RPL7P5 do not produce a functional protein and typically lack regulatory elements and coding potential. RPL7P5 is not a receptor, enzyme, transporter, or conventional drug target[1][6][8]. There is no evidence linking RPL7P5 itself to specific biological function, disease mechanism, or drug interactions in the literature. Reports referencing RPL7 pseudogenes commonly note their existence as genomic relics or markers of gene duplication events, not as functional molecules[3][4][8].\n\nExplanation and clarification:\n- The functional protein, Ribosomal protein L7 (RPL7), is well-characterized and involved in ribosome assembly, but RPL7P5 is a pseudogene: it is DNA with similarity to RPL7 but does not produce a functional ribosomal protein[1][6][8].\n- Pseudogenes are not therapeutic targets—they do not encode active proteins or participate directly in molecular pathways as drugs or biologics targets[8].\n- There is no evidence in research databases or product catalogs that RPL7P5 serves any biomarker, therapeutic, or pharmacological role[3][6].\n\nConclusion:\nRPL7P5 is a pseudogene, not a functional protein or valid drug/receptor target. The only information available concerns its genomic status as a processed pseudogene of RPL7; it plays no known active role in cell biology or therapeutics[1][6][8].

Other names
RPL7_18_1464RPL7P5

Beyond the preview

Go deeper on Ribosomal protein L7 pseudogene 5 (RPL7P5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 pseudogene 5 (RPL7P5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call